Principal Securities, Inc. Wave Life Sciences Ltd. Transaction History
Principal Securities, Inc.
- $4.14 Trillion
- Q3 2024
A detailed history of Principal Securities, Inc. transactions in Wave Life Sciences Ltd. stock. As of the latest transaction made, Principal Securities, Inc. holds 45 shares of WVE stock, worth $715. This represents 0.0% of its overall portfolio holdings.
Number of Shares
45
Previous 25
80.0%
Holding current value
$715
Previous $125,000
195.2%
% of portfolio
0.0%
Previous 0.0%
Shares
2 transactions
Others Institutions Holding WVE
# of Institutions
152Shares Held
97MCall Options Held
33KPut Options Held
57.2K-
Ra Capital Management, L.P. Boston, MA18.2MShares$289 Million1.37% of portfolio
-
Lee Ainslie Maverick Capital LTD | Dallas, Tx7.67MShares$122 Million0.75% of portfolio
-
Black Rock Inc. New York, NY6.74MShares$107 Million0.0% of portfolio
-
M28 Capital Management LP Stamford, CT6.16MShares$98 Million48.05% of portfolio
-
Siren, L.L.C. New York, NY5.72MShares$90.9 Million2.35% of portfolio
About Wave Life Sciences Ltd.
- Ticker WVE
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 86,820,096
- Market Cap $1.38B
- Description
- Wave Life Sciences Ltd., a clinical stage genetic medicine company, designs, optimizes, and produces novel stereopure oligonucleotides through PRISM, a discovery and drug developing platform. It is developing oligonucleotides target ribonucleic acid to reduce the expression of disease-promoting proteins or restore the production of functional pr...